| |||||||||||||||||||||||||||||||||||
# of Animals | Phenotype | Strain | Sex | Value | Units | Conditions | Record ID | Condition 1a | Condition 1b | ||||||||||||||||||||||||||
12 | percentage of study population developing experimental arthritis during a period of time | DA.PVG.1AV1-(D4Rat155-Spr) | both | 25 | % | Freund's incomplete adjuvant (200 ul) | 70197 | Freund's incomplete adjuvant (200 ul) | |||||||||||||||||||||||||||
24 | percentage of study population developing experimental arthritis during a period of time | DA.PVG.1AV1-(D4Rat155-Spr) | both | 100 | % | pristane (150 ul) | 69719 | pristane (150 ul) | |||||||||||||||||||||||||||
14 | percentage of study population developing experimental arthritis during a period of time | DA.PVG.1AV1-(D4Rat155-Spr) | both | 100 | % | type II collagen (500 ug) and Freund's incomplete adjuvant (100 ul) | 69712 | type II collagen (500 ug) | Freund's incomplete adjuvant (100 ul) |